ABCL-298 Diffuse Large B-Cell Lymphoma During the Covid-19 Pandemic in Two Tertiary Centers: The Israeli/Italian Study.

In both cohorts, patients' characteristics were comparable between the periods. Yet, more patients were diagnosed with DLBCL during the pandemic, and the interval between symptoms and diagnosis was longer compared to the year before. Still, there was no change in treatment in terms of dose density and intensity. The trend towards a shorter PFS during the outbreak in the Italian cohort can be explained by the older age of the patients treated during this period.